| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 121.87B | 115.11B | 113.51B | 107.85B | 98.15B | 218.35B |
| Gross Profit | 61.71B | 53.30B | 50.19B | 47.69B | 42.67B | 44.08B |
| EBITDA | 10.33B | 9.59B | 8.51B | 6.47B | 3.67B | 2.46B |
| Net Income | 5.64B | 3.48B | 2.78B | 1.89B | -775.00M | -4.95B |
Balance Sheet | ||||||
| Total Assets | 123.73B | 115.86B | 116.59B | 119.30B | 120.08B | 124.04B |
| Cash, Cash Equivalents and Short-Term Investments | 4.91B | 2.59B | 3.73B | 3.24B | 4.10B | 5.62B |
| Total Debt | 6.03B | 4.81B | 6.27B | 12.86B | 17.43B | 17.42B |
| Total Liabilities | 80.40B | 77.28B | 79.27B | 84.71B | 86.77B | 90.39B |
| Stockholders Equity | 43.33B | 38.58B | 37.32B | 34.59B | 33.31B | 33.64B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.79B | 7.06B | 4.91B | -141.00M | 1.22B |
| Operating Cash Flow | 0.00 | 6.73B | 10.17B | 7.56B | 2.50B | 4.30B |
| Investing Cash Flow | 0.00 | -3.90B | -2.19B | -3.02B | -3.30B | -3.61B |
| Financing Cash Flow | 0.00 | -3.97B | -7.49B | -5.40B | -715.00M | 1.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥997.74B | 9.13 | 9.37% | 2.59% | -1.22% | -10.82% | |
71 Outperform | ¥528.94B | 14.44 | 9.06% | 1.84% | 0.42% | 20.25% | |
66 Neutral | ¥636.20B | 22.09 | 7.58% | 2.58% | 6.52% | -31.67% | |
66 Neutral | ¥282.15B | 2.68 | 4.97% | 2.01% | 2.00% | -68.35% | |
65 Neutral | ¥1.11T | 14.50 | 9.25% | 1.48% | -2.86% | 14.93% | |
65 Neutral | ¥71.10B | 17.68 | ― | 1.09% | 7.55% | 89.45% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |